Premium
Modern‐day management of upper gastrointestinal haemorrhage
Author(s) -
Jairath V.,
Desborough M. J. R.
Publication year - 2015
Publication title -
transfusion medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 59
eISSN - 1365-3148
pISSN - 0958-7578
DOI - 10.1111/tme.12266
Subject(s) - medicine , etiology , blood transfusion , intensive care medicine , cirrhosis , tranexamic acid , upper gastrointestinal bleeding , fibrinogen , blood loss , surgery , endoscopy
SUMMARY Acute upper gastrointestinal haemorrhage ( AUGIH ) is a common medical emergency and can present with life threatening haemorrhage. In the UK , there are 70 000 hospital admissions per year. In the majority of cases, the aetiology is non‐variceal in origin, but in other cases it is due to variceal bleeding in patients with cirrhosis. It is also a leading indication for transfusion of blood components. This review explores recent randomised data on the efficacy and safety of red blood cell transfusion for AUGIH . In addition, the evidence base for use of other blood components and pro‐haemostatic pharmacological agents is discussed, including acid suppression, antifibrinolytics and fibrinogen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom